These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6264089)

  • 1. Therapeutic attempts in infants with nonketotic hyperglycinaemia.
    Pueschel SM; Cha CJ; Langon T
    J Ment Defic Res; 1981 Mar; 25(Pt 1):61-9. PubMed ID: 6264089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.
    Barshop BA; Breuer J; Holm J; Leslie J; Nyhan WL
    J Inherit Metab Dis; 1989; 12(1):72-9. PubMed ID: 2501586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early treatment of severe infantile glycine encephalopathy (nonketotic hyperglycinemia) with strychnine and sodium benzoate.
    Melançon SB; Dallaire L; Vincelette P; Potier M; Geoffroy G
    Prog Clin Biol Res; 1979; 34():217-29. PubMed ID: 531053
    [No Abstract]   [Full Text] [Related]  

  • 4. Ketamine and strychnine treatment of an infant with nonketotic hyperglycinaemia.
    Tegtmeyer-Metzdorf H; Roth B; Günther M; Theisohn M; Heinemann U; Adams HA; Sticht G
    Eur J Pediatr; 1995 Aug; 154(8):649-53. PubMed ID: 7588967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental hyperglycinaemia--an evaluation of the efficacy of strychnine therapy in nonketotic hyperglycinaemia.
    von Wendt L
    J Ment Defic Res; 1979 Sep; 23(3):195-205. PubMed ID: 513121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonketotic hyperglycinemia. Effects of therapy with strychnine.
    Warburton D; Boyle RJ; Keats JP; Vohr B; Peuschel S; Oh W
    Am J Dis Child; 1980 Mar; 134(3):273-5. PubMed ID: 6767393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of defective threonine metabolism in non-ketotic hyperglycinaemia.
    Krieger I; Nigro M
    J Inherit Metab Dis; 1983; 6(1):40-3. PubMed ID: 6408308
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic trial of NMDA antagonist for a nonketotic hyperglycinemic infant].
    Imai M; Kitajima H; Tokoro T; Kubo M; Maekawa K
    No To Hattatsu; 1995 Jul; 27(4):327-9. PubMed ID: 7612297
    [No Abstract]   [Full Text] [Related]  

  • 9. The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia.
    Wolff JA; Kulovich S; Yu AL; Qiao CN; Nyhan WL
    Am J Dis Child; 1986 Jun; 140(6):596-602. PubMed ID: 3706242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to sodium benzoate treatment in non-ketotic hyperglycinaemia.
    Walther F; Radke M; Krüger G; Hobusch D; Uhlemann M; Tittelbach-Helmrich W; Stolpe HJ
    Acta Paediatr Jpn; 1994 Feb; 36(1):75-9. PubMed ID: 8165914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
    Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
    J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia.
    Zammarchi E; Donati MA; Ciani F; Pasquini E; Pela I; Fiorini P
    Neuropediatrics; 1994 Oct; 25(5):274-6. PubMed ID: 7885541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonketotic hyperglycinemia treated with strychnine, a glycine receptor antagonist.
    Gitzelmann R; Steinmann B; Otten A; Dumermuth G; Herdan M; Reubi JC; Cuénod M
    Helv Paediatr Acta; 1978 Feb; 32(6):517-25. PubMed ID: 344282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strychnine therapy in nonketotic hyperglycinemia.
    Arneson D; Ch'ien LT; Chance P; Wilroy RS
    Pediatrics; 1979 Mar; 63(3):369-73. PubMed ID: 440838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-ketotic hyperglycinaemia. Clinical treatment, diet, and pathologico-anatomic changes (author's transl)].
    Leupold D; Przyrembel H; Heymer D; Hilgarth R; Krüger C; Peiffer J; Bremer HJ
    Z Kinderheilkd; 1974 Jan; 116(2):95-114. PubMed ID: 4816161
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical effects of serine medication in non-ketotic hyperglycinaemia due to deficiency of P-protein of the glycine cleavage complex.
    Wijburg FA; de Groot CJ; Schutgens RB; Barth PG; Tada K
    J Inherit Metab Dis; 1988; 11 Suppl 2():218-20. PubMed ID: 3141706
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of strychnine treatment during the neonatal period in three Finnish children with nonketotic hyperglycinemia.
    von Wendt L; Similä S; Saukkonen AL; Koivisto M
    Pediatrics; 1980 Jun; 65(6):1166-9. PubMed ID: 7375243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-methyl group metabolism in non-ketotic hyperglycinaemia: mildly elevated cerebrospinal fluid homocysteine levels.
    Van Hove JL; Lazeyras F; Zeisel SH; Bottiglieri T; Hyland K; Charles HC; Gray L; Jaeken J; Kahler SG
    J Inherit Metab Dis; 1998 Dec; 21(8):799-811. PubMed ID: 9870205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difficulties in assessing the effect of strychnine on the outcome of non-ketotic hyperglycinaemia. Observations on sisters with a mild T-protein defect.
    Haan EA; Kirby DM; Tada K; Hayasaka K; Danks DM
    Eur J Pediatr; 1986 Sep; 145(4):267-70. PubMed ID: 3769993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attempts at use of strychnine sulfate in the treatment of nonketotic hyperglycinemia.
    MacDermot KD; Nelson W; Reichert CM; Schulman JD
    Pediatrics; 1980 Jan; 65(1):61-4. PubMed ID: 7355037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.